Diabetes Discovery Reduces 'Life Threatening' Complication Risk
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The discovery of a new biological pathway may explain why people with type 2 diabetes are twice as prone to dangerous blood clots—putting them at risk of heart attack and stroke.
This is the conclusion of researchers from the University of Sydney, who say their findings may pave the way for new treatments that reduce this danger.
"People with type 2 diabetes have a higher risk of heart attacks and strokes. Part of the reason for this is that their platelets are hyper-reactive," paper author and hematologist professor Freda Passam told Newsweek.
Platelets are small cell fragments found in our blood that form clots to help stop bleeding. The high levels of blood sugar seen in diabetes, however, cause biochemical changes that make them "stickier", Passam explained, so they can clot when not needed to.
The hematologist continued: "Drugs like aspirin prevent platelets from clotting, but are three times less effective in people with type 2 diabetes. Understanding why platelets are more active in diabetes opens the door to develop drugs that target this newly discovered pathway."
In their study, the team found that the levels of a protein called "SEC61B" is significantly increased in the platelets—the tiny blood cells that help form clots—of people with type 2 diabetes.
The protein appears to disrupt calcium balance inside platelets, making them more likely to clump together and form clots, the researchers explained.
The researchers found that blocking SEC61B activity with an antibiotic called anisomycin reduced platelet clumping in both human samples and animal models.
Smiling woman checking her blood sugar levels.
Smiling woman checking her blood sugar levels.
JLco -Around 1 in 10 Americans (more than 38 million people) live with diabetes, of which 90–95 percent have type 2, which occurs when insulin doesn't work properly or there's not enough of it.
While type 2 diabetes typically develops in people aged 45 and over, children, teens and young adults are increasingly developing the condition as well.
"People living with type 2 diabetes are vulnerable to increased risk of blood clots," Passam said in a statement. "These exciting findings identify a whole new way to reduce this risk and help prevent life-threatening complications like heart attack and stroke."
In their study, the team analyzed both human and mouse platelets, discovering that SEC61B contributes to calcium leakage from the platelets' stores, making the cell fragments more reactive.
The Australia-based researchers noted that the condition is "more prevalent in Aboriginal and Torres Strait Islander peoples and in rural and regional communities."
"Cardiovascular disease is a leading cause of death in this group, partly due to the heightened activity of platelets—the tiny blood cells that help form clots," they explained.
"This heightened platelet sensitivity to clotting also makes traditional anti-coagulant treatments less effective in people with type 2 diabetes, limiting the options to reduce the risk of cardiovascular disease."
Treatments targeting SEC61B are still in early stages. However, the researchers believe pre-clinical trials in animals could begin within 1–2 years, with potential therapies for patients likely to be available in the next decade.
Do you have a tip on a health story that Newsweek should be covering? Do you have a question type 2 diabetes? Let us know via health@newsweek.com.
Reference
Kong, Y. X., Rehan, R., Moreno, C. L., Madsen, S., Zhang, Y., Zhao, H., Qi, M., Houlahan, C., Cartland, S. P., Robertshaw, D., Trang, V., Ong, F. J. L., Liu, M., Cheng, E., Alwis, I., Dupuy, A., Cielesh, M., Cooke, K. C., Potter, M., Stӧckli, J., Morahan, G., Kalev-Zylinska, M., Rondina, M. T., Schulman, S., Yang, J., Neely, G. G., Schoenwaelder, S., Jackson, S., James, D., Kavurma, M. M., Hocking, S., Twigg, S. M., Weaver, J., Larance, M., & Passam, F. H. (2025). SEC61B regulates calcium flux and platelet hyperreactivity in diabetes. Journal of Clinical Investigation. https://doi.org/10.1172/JCI184597
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Fatality as 2 people fall from overpass in CBD
Two people are dead after falling from an overpass in the Sydney CBD, closing lanes of the Harbour Bridge on Saturday. Police are investigating how the people came to fall from the Western Distributor onto Harbour Street at about 9.45am. A man and a woman, both believed to be in their 40s, died at the scene. 'Officers from Sydney City Police Area Command have established a crime scene and have commenced an investigation into the circumstances surrounding the incident,' NSW Police said in a statement. Two southbound lanes of the Harbour Bridge have been closed. Authorities also closed off Harbour Street in the Sydney CBD to southbound traffic. The Transport Management Centre has urged motorists to allow extra time due to the incident. 'Southbound motorists should continue on the Western Distributor, before taking the Harris Street off-ramp, Harris Street, William Henry Street and Pier Street to access Harbour Street and the city's south,' the centre said. Don't go it alone. Please reach out for help. Lifeline: 13 11 14 or Beyond Blue: 1300 22 4636 or Beyond Blue's coronavirus support service: 1800 512 348 or Kids Helpline: 1800 55 1800 or Headspace: 1800 650 890 or Are you anxious? Take the Beyond Blue quiz to see how you're tracking and whether you could benefit from support
Boston Globe
an hour ago
- Boston Globe
In 2023, Mass. hospitals pushed executive pay to new heights
That total reflected base salary, bonus pay, retirement benefits, and more. It was a 40.1 percent increase from the prior year, and included roughly $4.3 million in bonus and incentive pay. The amount is the highest total compensation reported by a Massachusetts hospital CEO in at least the last decade. In a statement, MGB Board Chairman Scott Sperling stood by Klibanski's compensation package, which he said was based on industry benchmarks with input from a consultant. Advertisement 'The challenges facing our industry are many, and the competition for top talent is unprecedented. It is imperative that we actively and robustly recruit and retain at every level to ensure we can expertly care for patients and communities for years to come,' Sperling said. 'Our objective, on average, is to base compensation for our senior executives at the 50th percentile of the current market, with performance driving any adjustments,' he said. Advertisement Previously, the health system has pointed to the leaders at other national health systems than her Massachusetts colleagues. Indeed, her 2023 salary ranked below some, including CEO of New York-based Northwell Health ($9 million) and Arizona-based Banner Health ($14 million). However Klibanski eclipsed others, including the CEOs at Cleveland Clinic ($7 million), and Mayo Clinic ($4.3 million). While the most recent compensation report lags by two years, Sperling pointed to how Klibanski had handled recent challenges as an example of what he said was her 'clear-eyed leadership,' including disruptive federal actions that have threatened research and an inpatient capacity crises. Dr. Anne Klibanski, with then-Governor Charlie Baker, pictured speaking at a coronavirus briefing in 2020. Sam Doran/Pool 'The Board of Directors fully supports Dr. Klibanski's compensation package ... which reflects her achievements and stewardship of an organization of this size and complexity,' Sperling said. Klibanski had plenty of company in the ranks of well-paid Massachusetts hospital executives in 2023. Dr. Kevin Tabb, who heads the state's second largest health system, Beth Israel Lahey Health, also reported a sizable increase, with his $5.4 million in total compensation representing a 93 percent increase from the prior year. The increases were a return to compensation Tabb reported in 2021, and were largely thanks to increases in bonus and incentive comp, as well as retirement and other deferred compensation. Dr. Eric Dickson, chief executive of UMass Memorial Health, reported a nearly 26 percent increase in total comp, to $3.9 million. The hospital said it changed its retirement plan in 2023, prompting an early payout of some benefits. That shift subsequently boosted the incentive compensation of several executives, including Dickson. Advertisement Similarly, Dr. Michael Gustafson, who left as president of UMass's flagship hospital, UMass Memorial Medical Center, in July 2023, reported a 60 percent increase in total comp to $2.8 million. Michael Dandorph, who helms Tufts Medicine, also reported a double digit increase in total comp. His $2.1 million total compensation was 32 percent higher than the previous year. Dr. Alastair Bell, CEO of Boston Medical Center Health System since June 2023 and its president since November 2022, saw his total comp increase by 34 percent to $1.9 million. Large jumps weren't universal. Other executives saw smaller changes including Dr. Kevin Churchwell ($3.2 million, down 5 percent) at Boston Children's Hospital, Dr. Mark Keroack ($2.8 million, a 4.8 percent increase) at Baystate Health where he served until 2024, and Dr. Laurie Glimcher ($2.5 million, up 5 percent) at Dana-Farber Cancer Institute which she led until 2024. Dr. Kevin Churchwell, CEO of Boston Children's Hospital, saw his compensation go down 5 percent from 2022 to 2023. Erin Clark/Globe Staff The data tracks with a study by the Harvard School of Public Health, which showed that executives overseeing large teaching hospitals nationally were the highest compensated. The study, However, there was no association between compensation and the degree of community benefit a hospital provided, nor was higher compensation associated with better patient mortality rates or readmission rates, according to the study. The Massachusetts Nurses Association lambasted executives for the pay, particularly as they said the quality of care at hospitals across the state has suffered. 'At a time when nearly 80% of Massachusetts nurses say hospital care has gotten worse in the last two years, it is deeply troubling that hospital CEOs are taking home enormous compensation packages while continuing to fail to ensure safe conditions for patients and direct care providers,' the nurses union said in a statement. Advertisement 'The very same executives receiving millions of dollars per year are making decisions not to invest in bedside care or listen to caregivers,' it said. The salaries reflect a time when hospitals were just beginning to climb out of the effects from the pandemic. Volume and revenue had begun to rebound in the year that for many hospitals ended September 2023, with Often, hospital executive compensation has been tied to a system's size and comparisons to others in the market, said Susan Malanowski, managing director of compensation consultant the Wilson Group. There are pressures on boards to hire competent executives, and the pool of applicants is smaller than it has been in the past. 'To be competitive, it is what it is,' Malanowski said. 'There is not really a big supply of competent CEOs or c-suite (executives).' While the most recent compensation data is for 2023, hospitals will be harder pressed to support large pay packages in 2025 and onward, Malanowski predicted. Uncertainty at the federal level will mean non-profit institutions will have to be more circumspect about where they set base salaries, and compensation increases are projected to be smaller. Advertisement Jessica Bartlett can be reached at
Yahoo
4 hours ago
- Yahoo
Three years after his death, cricketer Shane Warne's legacy lives on with heart health checks
BRISBANE, Australia (AP) — Cricketer Shane Warne's legacy lives on more than three years after the death of the great spin bowler from a heart attack at the age of 52. Warne died in March 2022 after suffering cardiac arrest while on holiday on the Thai island of Koh Samui. The cause of his sudden death led his business team and family to unite to honor his life and create Shane Warne Legacy. The charity set up free heart health checkup machines at the Melbourne Cricket Ground during the past two Boxing Day tests. The results of the stadium checks along with 311 community pharmacy stations across Australia were analyzed as part of a Monash University-led study. A total of 76,085 people were screened across seven weeks from mid-December 2023 to the end of January 2024, including 7,740 at the MCG. The research published in the Journal of the American College of Cardiology on Friday showed almost seven out of 10 (68.9%) had at least one uncontrolled risk factor for heart disease. Factors were elevated blood pressure readings (37.2%), elevated body mass index (60.5%) and being a smoker (12.1%). Cricket spectators who did the free checks, mostly men aged 35 to 64, had higher rates of elevated blood pressure and body mass index than those screened at pharmacies. Warne revived and elevated the art of leg-spin bowling when he emerged on the international scene in the 1990s and was a central character in one of Australia's most successful eras in the sport. He also was one of cricket's larger-than-life showmen. Warne held the record for the most test wickets with 708 when he retired in 2007 after his 145th match. Only Sri Lanka off-spinner Muttiah Muralitharan has passed him, with 800. 'Meeting people where they are, whether that's at their local pharmacy or the MCG, can make all the difference to health outcomes,' said Dr. Sean Tan, a cardiologist and researcher at the Victorian Heart Institute. Warne's long-time personal assistant Helen Nolan said the findings reinforced Shane Warne Legacy's mission to turn his death into a catalyst for change. The charity's chief executive described the results as 'bittersweet.' 'We're proud to have helped thousands take their heart health seriously but we know there's still work to do,' Nolan said. 'Shane would have wanted this to make a massive difference.' ___ AP cricket:
